No SARS-CoV-2 reinfection among staff health-care workers: Prospective hospital-wide screening during the first and second waves in Paris

Journal of Clinical Virology - Tập 145 - Trang 104999 - 2021
Maxime Wack1,2, Hélène Péré3,4, Nathalie Demory-Guinet5, Najiby Kassis-Chikhani6, Laurence Janot5, Benoit Vedie7, Laure Izquierdo3, Laurent Bélec2,3,8, David Veyer3,4
1Département d'Informatique Médicale, Biostatistiques et Santé Publique, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
2Faculté de Médecine, Université de Paris, Paris, 75005, France
3Laboratoire de Virologie, Service de Microbiologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
4Unité de Génomique Fonctionnelle des Tumeurs Solides, Centre de Recherche des Cordeliers, INSERM, Université Paris, Paris, 75005, France
5Service de Médecine du Travail, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
6Unité d'Hygiène Hospitalière, Service de Microbiologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
7Laboratoire de Biochimie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, 75015, France
8INSERM U970, PARCC, hôpital européen Georges Pompidou, Faculté de Médecine, Université de Paris, Paris, 75015, France

Tài liệu tham khảo

Contejean, 2020, Comparing dynamics and determinants of severe acute respiratory syndrome coronavirus 2 transmissions among healthcare workers of adult and pediatric settings in central Paris, Clin. Infect. Dis Hunter, 2020, 395, e77 Amanat, 2020, A serological assay to detect SARS-CoV-2 seroconversion in humans, Nat. Med, 26, 1033, 10.1038/s41591-020-0913-5 Canedo-Marroquín, 2020, SARS-CoV-2: immune response elicited by infection and development of vaccines and treatments, Front. Immunol. Front. Media S.A., 11 Galipeau, 2020, Humoral responses and serological assays in SARS-CoV-2 infections, 11 Jarjour, 2021, 14 Le Bert, 2020, SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls, Nature, 584, 457, 10.1038/s41586-020-2550-z Babiker, 2020, The importance and challenges of identifying SARS-CoV-2 reinfections, J. Clin. Microbiol Cohen, 2020, Reinfection with SARS-CoV-2: implications for vaccines, Clin. Infect. Dis Gupta, 2020, Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19, JAMA Intern. Med. [Internet] Yu, 2020, Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients, Clin. Infect. Dis, 10.1093/cid/ciaa345 Péré, 2020, Nasal swab sampling for SARS-CoV-2: a convenient alternative in times of nasopharyngeal swab shortage, J. Clin. Microbiol., 58, 10.1128/JCM.00721-20 Péré, 2020, Unexpected diagnosis of COVID-19-associated disorders by SARS-CoV-2-specific serology, J. Clin. Virol, 132 Huang, 2015, A richly interactive exploratory data analysis and visualization tool using electronic medical records Clinical decision-making, knowledge support systems, and theory, BMC Med. Inform. Decis. Mak, 15, 10.1186/s12911-015-0218-7 Péré, 2020, Sequential SARS-CoV-2 IgG assays as confirmatory strategy to confirm equivocal results: hospital-wide antibody screening in 3,569 staff health care workers in Paris, J. Clin. Virol. [Internet], 132 Salje, 2020, Estimating the burden of SARS-CoV-2 in France, Science (80-), 369, 208, 10.1126/science.abc3517 Abu-Raddad, 2020, Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting, Clin. Infect. Dis Tomassini, 2020, Setting the criteria for SARS-CoV-2 reinfection – six possible cases, J. Infect 2020, Investigative criteria for suspected cases of SARS-CoV-2 reinfection (ICR) [Internet], Cent. Dis. Control Prev Wyllie D., Mulchandani R., Jones H.E., Taylor-Phillips S., Brooks T., Charlett A., et al. SARS-CoV-2 responsive T cell numbers are associated with protection from COVID-19: a prospective cohort study in keyworkers. medRxiv. 2020. p. 2020.11.02.20222778. Lumley S.F., O'Donnell D., Stoesser N.E., Matthews P.C., Howarth A., Hatch S.B., et al. Antibodies to SARS-CoV-2 are associated with protection against reinfection. medRxiv. 2020. p. 2020.11.18.20234369. Overbaugh, 2020, Understanding protection from SARS-CoV-2 by studying reinfection, Nat. Med, 26, 1680, 10.1038/s41591-020-1121-z Dan, 2021, Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection, Science (80-), eabf4063, 10.1126/science.abf4063 Chung, 2021, COVID-19 vaccines: the status and perspectives in delivery points of view. Vol. 170, 1 Organization, 2020 Dooling, 2020, The advisory committee on immunization practices’ interim recommendation for allocating initial supplies of COVID-19 Vaccine — United States, 2020, MMWR Morb. Mortal Wkly. Rep. [Internet], 69, 1857, 10.15585/mmwr.mm6949e1 COVID-19: the green book, chapter 14a - GOV.UK [Internet]. [cited 2021 Jan 29]. Available from: https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a. Haute Autorité de Santé - Stratégie de vaccination contre le Sars-Cov-2 - Recommandations préliminaires sur la stratégie de priorisation des populations à vacciner [Internet]. [cited 2021 Jan 29]. Available from: https://www.has-sante.fr/jcms/p_3221338/fr/strategie-de-vaccination-contre-le-sars-cov-2-recommandations-preliminaires-sur-la-strategie-de-priorisation-des-populations-a-vacciner. West, 2020, COVID-19 antibody tests: a valuable public health tool with limited relevance to individuals Kirby, 2021, New variant of SARS-CoV-2 in UK causes surge of COVID-19, Lancet Respir. Med, 10.1016/S2213-2600(21)00005-9